Daniel Wendling, Muhsen Murad, Sandra Mathieu, Eric Berger, Lucien Rumbach. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdalimumabAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyCentral Nervous System Infections/immunologyCentral Nervous System Infections/microbiologyDrug Therapy, CombinationHumansImmunocompromised HostMagnetic Resonance ImagingMaleMethotrexate/therapeutic useMiddle AgedNocardia Infections/etiologyNocardia Infections/immunologyTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsTumor Necrosis Factor-alphaAdalimumabMethotrexate
Year: 2008 PMID: 18322977
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666